Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Class II · Cleared Nov 20, 2020
| K-number | K193576 |
| Device name | Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device (Solitaire Revascularization Device) |
| Applicant | Micro Therapeutics, Inc. d/b/a ev3 Neurovascular |
| Product code | POL |
| Device class | Class II |
| Decision date | Nov 20, 2020 |
| Decision | Substantially Equivalent |
| Regulation | 882.5600 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov